Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RALTEGRAVIR vs RAMUCIRUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RALTEGRAVIR vs RAMUCIRUMAB: Safety Overview

Metric RALTEGRAVIR RAMUCIRUMAB
Total FAERS Reports 8,612 5,357
Deaths Reported 985 1,444
Death Rate 11.4% 27.0%
Hospitalizations 2,088 2,066
Average Patient Age 43.5 yrs 63.9 yrs
% Female Patients 38.5% 33.0%
FDA Approval Date Dec 19, 2024 N/A
Manufacturer Proficient Rx LP Eli Lilly and Company
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription